BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37966247)

  • 1. Silent Corticotroph Staining Pituitary Neuroendocrine Tumors: Prognostic Significance in Radiosurgery.
    Maragkos GA; Mantziaris G; Pikis S; Chytka T; Liscak R; Peker S; Samanci Y; Bindal SK; Niranjan A; Lunsford LD; Kaur R; Madan R; Tripathi M; Pangal DJ; Strickland BA; Zada G; Langlois AM; Mathieu D; Warnick RE; Patel S; Minier Z; Speckter H; Kondziolka D; Lee CC; Vance ML; Sheehan JP
    Neurosurgery; 2023 Dec; 93(6):1407-1414. PubMed ID: 37966247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study.
    Cohen-Inbar O; Xu Z; Lee CC; Wu CC; Chytka T; Silva D; Sharma M; Radwan H; Grills IS; Nguyen B; Siddiqui Z; Mathieu D; Iorio-Morin C; Wolf A; Cifarelli CP; Cifarelli DT; Lunsford LD; Kondziolka D; Sheehan JP
    J Neurooncol; 2017 Oct; 135(1):67-74. PubMed ID: 28913674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
    Pomeraniec IJ; Xu Z; Lee CC; Yang HC; Chytka T; Liscak R; Martinez-Alvarez R; Martinez-Moreno N; Attuati L; Picozzi P; Kondziolka D; Mureb M; Bernstein K; Mathieu D; Maillet M; Ogino A; Long H; Kano H; Lunsford LD; Zacharia BE; Mau C; Tuanquin LC; Cifarelli C; Arsanious D; Hack J; Warnick RE; Strickland BA; Zada G; Chang EL; Speckter H; Patel S; Ding D; Sheehan D; Sheehan K; Kvint S; Buch LY; Haber AR; Shteinhart J; Vance ML; Sheehan JP
    J Neurosurg; 2022 Mar; 136(3):813-821. PubMed ID: 34560630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study.
    Xu Z; Ellis S; Lee CC; Starke RM; Schlesinger D; Lee Vance M; Lopes MB; Sheehan J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):903-10. PubMed ID: 25216855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery for nonfunctioning pituitary tumor: A multicenter study of new pituitary hormone deficiency.
    Dumot C; Mantziaris G; Dayawansa S; Peker S; Samanci Y; Nabeel AM; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad RM; Abdelsalam AR; Liscak R; May J; Mashiach E; De Nigris Vasconcellos F; Bernstein K; Kondziolka D; Speckter H; Mota R; Brito A; Bindal SK; Niranjan A; Lunsford DL; Benjamin CG; Abrantes de Lacerda Almeida T; Mao J; Mathieu D; Tourigny JN; Tripathi M; Palmer JD; Matsui J; Crooks J; Wegner RE; Shepard MJ; Vance ML; Sheehan JP
    Neuro Oncol; 2024 Apr; 26(4):715-723. PubMed ID: 38095431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant versus on-progression Gamma Knife radiosurgery for residual nonfunctioning pituitary adenomas: a matched-cohort analysis.
    Mantziaris G; Pikis S; Chytka T; Liščák R; Sheehan K; Sheehan D; Peker S; Samanci Y; Bindal SK; Niranjan A; Lunsford LD; Kaur R; Madan R; Tripathi M; Pangal DJ; Strickland BA; Zada G; Langlois AM; Mathieu D; Warnick RE; Patel S; Minier Z; Speckter H; Xu Z; Kormath Anand R; Sheehan JP
    J Neurosurg; 2023 Jun; 138(6):1662-1668. PubMed ID: 36401547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Crooke's changes in recurrence and remission after gamma knife radiosurgery.
    Cordeiro D; Xu Z; Nasser M; Lopes B; Vance ML; Sheehan J
    J Neurooncol; 2019 Mar; 142(1):171-181. PubMed ID: 30607704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.
    Pomeraniec IJ; Kano H; Xu Z; Nguyen B; Siddiqui ZA; Silva D; Sharma M; Radwan H; Cohen JA; Dallapiazza RF; Iorio-Morin C; Wolf A; Jane JA; Grills IS; Mathieu D; Kondziolka D; Lee CC; Wu CC; Cifarelli CP; Chytka T; Barnett GH; Lunsford LD; Sheehan JP
    J Neurosurg; 2018 Sep; 129(3):648-657. PubMed ID: 29076785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
    Amano T; Masumoto T; Watanabe D; Hoshiai S; Mori K; Sakamoto N; Kino H; Akutsu H; Nakajima T
    Jpn J Radiol; 2023 Sep; 41(9):938-946. PubMed ID: 37027094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study.
    Sheehan JP; Starke RM; Mathieu D; Young B; Sneed PK; Chiang VL; Lee JY; Kano H; Park KJ; Niranjan A; Kondziolka D; Barnett GH; Rush S; Golfinos JG; Lunsford LD
    J Neurosurg; 2013 Aug; 119(2):446-56. PubMed ID: 23621595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.
    Graffeo CS; Link MJ; Brown PD; Young WF; Pollock BE
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):618-623. PubMed ID: 29678524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Effective Dose as a Predictor of Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis and Cohort Study of Patients Treated Using Contemporary Techniques.
    Graffeo CS; Perry A; Link MJ; Brown PD; Young WF; Pollock BE
    Neurosurgery; 2021 Mar; 88(4):E330-E335. PubMed ID: 33469668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term radiographic and endocrinological outcomes of stereotactic radiosurgery for recurrent or residual nonfunctioning pituitary adenomas.
    Shaaban A; Dumot C; Mantziaris G; Dayawansa S; Peker S; Samanci Y; Nabeel AM; Reda WA; Tawadros SR; Abdel Karim K; El-Shehaby AMN; Emad Eldin RM; Ragab Abdelsalam A; Liscak R; May J; Mashiach E; De Nigris Vasconcellos F; Bernstein K; Kondziolka D; Speckter H; Mota R; Brito A; Bindal SK; Niranjan A; Lunsford LD; Benjamin CG; Almeida T; Mao JZ; Mathieu D; Tourigny JN; Tripathi M; Palmer JD; Matsui J; Crooks J; Wegner RE; Shepard MJ; Sheehan JP
    J Neurosurg; 2024 Mar; ():1-8. PubMed ID: 38518285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma Knife radiosurgery for the treatment of Nelson's syndrome: a multicenter, international study.
    Cordeiro D; Xu Z; Li CE; Iorio-Morin C; Mathieu D; Sisterson ND; Kano H; Attuati L; Picozzi P; Sheehan KA; Lee CC; Liscak R; Jezkova J; Lunsford LD; Sheehan J
    J Neurosurg; 2019 Jul; ():1-6. PubMed ID: 31299652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine Remission After Pituitary Stereotactic Radiosurgery: Differences in Rates of Response for Matched Cohorts of Cushing Disease and Acromegaly Patients.
    Trifiletti DM; Xu Z; Dutta SW; Quiñones-Hinojosa A; Peterson J; Vance ML; Sheehan JP
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):610-617. PubMed ID: 29678528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence.
    Strickland BA; Shahrestani S; Briggs RG; Jackanich A; Tavakol S; Hurth K; Shiroishi MS; Liu CJ; Carmichael JD; Weiss M; Zada G
    J Neurosurg; 2021 May; 135(6):1706-1713. PubMed ID: 33962375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
    Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
    World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism.
    Starke RM; Williams BJ; Jane JA; Sheehan JP
    J Neurosurg; 2012 Jul; 117(1):129-35. PubMed ID: 22577749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
    Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.